F-18-FDG uptake in tuberculosis

被引:101
作者
Bakheet, SMB
Powe, J
Ezzat, A
Rostom, A
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Radiol MBC 28, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia
关键词
tuberculous lymphadenitis and pneumonitis; F-18 FDG PET whole-body scan; false-positive results;
D O I
10.1097/00003072-199811000-00003
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Two patients are described who showed abnormal fluorine-18 fiuorodeoxyglucose (F-18 FDG) uptake that was due to benign disease, specifically tuberculous lymphadenitis and pneumonitis. The first patient had ulceration and oozing of the left nipple that was related to Paget's disease. An F-18 FDG PET, whole-body scan, which was performed for staging, showed no breast uptake. However, there was intense multifocal uptake in mediastinal, supraclavicular, and para-aortic areas that was confirmed radiologically to represent widespread lymphadenopathy. Pathologic examination of a mediastinal lymph node showed active tuberculosis. The second patient showed intense focal F-18 FDG uptake in mediastinal and supraclavicular areas and para-aortic lymphadenopathy due to non-Hodgkin's lymphoma. In addition, there was abnormal F-18 FDG lung uptake that revealed the presence of acid-fast bacilli on bronchial ravage. Intense focal F-18 FDG uptake in widespread lymphadenopathy or in the lung could be caused by infectious diseases such as tuberculosis. This possibility should be considered when whole-body scans of patients with cancer are interpreted, especially in those with a high incidence of infectious disease.
引用
收藏
页码:739 / 742
页数:4
相关论文
共 27 条
[1]  
BAKHEET SM, 1998, IN PRESS SEMIN NUCL
[2]  
Bakheet SMB, 1998, J NUCL MED, V39, P234
[3]   PET and [F-18]-FDG in oncology: A clinical update [J].
Conti, PS ;
Lilien, DL ;
Hawley, K ;
Keppler, J ;
Grafton, ST ;
Bading, JR .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (06) :717-735
[4]   DETECTION OF PRIMARY AND RECURRENT LUNG-CANCER BY MEANS OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG PET) [J].
DUHAYLONGSOD, FG ;
LOWE, VJ ;
PATZ, EF ;
VAUGHN, AL ;
COLEMAN, RE ;
WOLFE, WG .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (01) :130-140
[5]   DECISION LOGIC FOR RETREATMENT OF ASYMPTOMATIC LUNG-CANCER RECURRENCE EASED ON POSITRON EMISSION TOMOGRAPHY FINDINGS [J].
FRANK, A ;
LEFKOWITZ, D ;
JAEGER, S ;
GOBAR, L ;
SUNDERLAND, J ;
GUPTA, N ;
SCOTT, W ;
MAILLIARD, J ;
LYNCH, H ;
BISHOP, J ;
THORPE, P ;
DEWAN, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05) :1495-1512
[6]  
GOLBERG M, 1993, RADIOGRAPHICS, V13, P1047
[7]  
HANSON PS, 1995, J NUCL MED, V36, pP193
[8]  
HUBNER KF, 1995, CLIN NUCL MED, V20, P283
[9]  
INOUE T, 1995, J NUCL MED, V36, P788
[10]   Evaluation of pulmonary lesions with FDG-PET - Comparison of findings in patients with and without a history of prior malignancy [J].
Knight, SB ;
Delbeke, D ;
Stewart, JR ;
Sandler, MP ;
Ebers, T .
CHEST, 1996, 109 (04) :982-988